These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3171697)

  • 1. Distribution of radiolabeled human and mouse monoclonal IgM antibodies in murine models.
    Halpern SE; Hagan PL; Chen A; Birdwell CR; Bartholomew RM; Burnett KG; David GS; Poggenburg K; Merchant B; Carlo DJ
    J Nucl Med; 1988 Oct; 29(10):1688-96. PubMed ID: 3171697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of internally labeled monoclonal antibodies as a gold standard: comparison of biodistribution of 75Se-, 111In-, and 125I-labeled monoclonal antibodies in osteogenic sarcoma xenografts in nude mice.
    Koizumi M; Endo K; Watanabe Y; Saga T; Sakahara H; Konishi J; Yamamuro T; Toyama S
    Cancer Res; 1989 Apr; 49(7):1752-7. PubMed ID: 2924318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microdistribution of specific rat monoclonal antibodies to mouse tissues and human tumor xenografts.
    Kennel SJ; Falcioni R; Wesley JW
    Cancer Res; 1991 Mar; 51(5):1529-36. PubMed ID: 1997194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indium-111- and yttrium-90-labeled human monoclonal immunoglobulin M targeting of human ovarian cancer in mice.
    Borchardt PE; Quadri SM; Freedman RS; Vriesendorp HM
    J Nucl Med; 1998 Mar; 39(3):476-84. PubMed ID: 9529295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability, characterization, and kinetics of 111In-labeled monoclonal antitumor antibodies in normal animals and nude mouse-human tumor models.
    Halpern SE; Hagan PL; Garver PR; Koziol JA; Chen AW; Frincke JM; Bartholomew RM; David GS; Adams TH
    Cancer Res; 1983 Nov; 43(11):5347-55. PubMed ID: 6616469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse.
    Goodwin DA; Meares CF; McCall MJ; Haseman MK; McTigue M; Diamanti CI; Chaovapong W
    J Nucl Med; 1985 May; 26(5):493-502. PubMed ID: 3921673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical analysis of intraperitoneal administration of 111In-labeled human tumor reactive monoclonal IgM AC6C3-2B12.
    Quadri SM; Malik AB; Tang XZ; Patenia R; Freedman RS; Vriesendorp HM
    Cancer Res; 1995 Dec; 55(23 Suppl):5736s-5742s. PubMed ID: 7493338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of 111In- and 125I-labeled antiTac single-chain Fv recombinant immunotoxin.
    Kobayashi H; Kao CH; Kreitman RJ; Le N; Kim MK; Brechbiel MW; Paik CH; Pastan I; Carrasquillo JA
    J Nucl Med; 2000 Apr; 41(4):755-62. PubMed ID: 10768579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental therapy of human breast tumors with 131I-labeled monoclonal antibodies prepared against the human milk fat globule.
    Ceriani RL; Blank EW
    Cancer Res; 1988 Aug; 48(16):4664-72. PubMed ID: 3396015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018.
    Murray JL; Rosenblum MG; Lamki L; Glenn HJ; Krizan Z; Hersh EM; Plager CE; Bartholomew RM; Unger MW; Carlo DJ
    J Nucl Med; 1987 Jan; 28(1):25-33. PubMed ID: 3794809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antibody as carrier of oligomers of peptidomimetic alphavbeta3 antagonist to target tumor-induced neovasculature.
    Shin IS; Jang BS; Danthi SN; Xie J; Yu S; Le N; Maeng JS; Hwang IS; Li KC; Carrasquillo JA; Paik CH
    Bioconjug Chem; 2007; 18(3):821-8. PubMed ID: 17375899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of mass of 111In-benzyl-EDTA monoclonal antibody on hepatic uptake and processing in mice.
    Adams GP; DeNardo SJ; Deshpande SV; DeNardo GL; Meares CF; McCall MJ; Epstein AL
    Cancer Res; 1989 Apr; 49(7):1707-11. PubMed ID: 2493983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between in vitro binding activity and in vivo tumor accumulation of radiolabeled monoclonal antibodies.
    Sakahara H; Endo K; Koizumi M; Nakashima T; Kunimatsu M; Watanabe Y; Kawamura Y; Nakamura T; Tanaka H; Kotoura Y
    J Nucl Med; 1988 Feb; 29(2):235-40. PubMed ID: 3162255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
    Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
    J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor size: effect on monoclonal antibody uptake in tumor models.
    Hagan PL; Halpern SE; Dillman RO; Shawler DL; Johnson DE; Chen A; Krishnan L; Frincke J; Bartholomew RM; David GS
    J Nucl Med; 1986 Mar; 27(3):422-7. PubMed ID: 3486953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human sarcoma-associated murine monoclonal antibody labeled with indium-111, gallium-67, and iodine-125.
    Bartal AH; Lavie E; Boazi M; Weininger J; Bitton M; Iosilevsky G; Front D; Hirshaut Y; Robinson E
    NCI Monogr; 1987; (3):153-5. PubMed ID: 3821913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human biodistribution of 111In-labeled B72.3 monoclonal antibody.
    Harwood SJ; Carroll RG; Webster WB; Zangara LM; Laven DL; Morrissey MA; Sinni BJ
    Cancer Res; 1990 Feb; 50(3 Suppl):932s-936s. PubMed ID: 2297744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake and metabolism of 111In-labeled monoclonal antibody B6.2 by the rat liver.
    Jones PL; Brown BA; Sands H
    Cancer Res; 1990 Feb; 50(3 Suppl):852s-856s. PubMed ID: 2297733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
    Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA
    J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody.
    van Schaijk FG; Oosterwijk E; Soede AC; Broekema M; Frielink C; McBride WJ; Goldenberg DM; Corstens FH; Boerman OC
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7130s-7136s. PubMed ID: 16203812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.